BioNTech SE American Depositary Share (BNTX)
NASDAQ
Closed
Oct 6, 2026
Day's Range
95.3152 wk Range
79.52Overview - BNTX - BioNTech SE American Depositary Share
Key Statistics
Valuation
Enterprise Value
12.57B
P/E (Trailing)
‪160.80‬
P/E (Forward)
‪-17.53‬
PEG Ratio
‪1.56‬
Price / Sales (TTM)
‪9.18‬
Price / Book
‪1.21‬
EV / EBITDA
‪-8.10‬
Profitability
Gross Margin
‪8.14%‬
Profit Margin
‪-63.63%‬
Operating Margin
‪-806.62%‬
Return on Assets
‪-5.41%‬
Return on Equity
‪-9.30%‬
Ownership
Shares Outstanding
251.20M
Float
108.99M
Short % of Shares Outstanding
‪3.48%‬
Held by Insiders
‪57.28%‬
Held by Institutions
‪20.47%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪98.43‬
200-Day Avg
‪97.69‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
20 analysts
Average price target
‪$ 121.48‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BNTX - BioNTech SE American Depositary Share
Peers - BNTX - BioNTech SE American Depositary Share
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
- AXSMNASDAQAxsome Therapeutics Inc.9.37BMarket Cap+33.09%52-week change-48.69P/E (Trailing)‪-24.67%‬Profit Margin
Profile Summary - BNTX - BioNTech SE American Depositary Share
About
BioNTech SE American Depositary Share is the U.S.-traded depositary share of BioNTech SE, a Germany-based biotechnology company focused on immunotherapy and vaccines. The company develops cancer therapeutics, including individualized treatment approaches such as personalized immunotherapies, and also works on vaccines…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
